Immediate Impact

14 by Nobel laureates 17 from Science/Nature 57 standout
Sub-graph 1 of 20

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Principles and therapeutic applications of adaptive immunity
2024 Standout
1 intermediate paper

Works of Robert C. Kane being referenced

FDA Approval: Blinatumomab
2015
U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
2014

Author Peers

Author Last Decade Papers Cites
Robert C. Kane 617 426 1117 1367 32 3.0k
Ronald G. Stoller 565 529 1981 908 63 3.4k
Ramzi Dagher 440 646 831 958 38 2.5k
P Selby 406 294 1009 634 57 2.5k
Jacques Jolivet 796 407 1037 1666 91 3.9k
Susan L. Kelley 305 277 877 1304 26 3.4k
Catherine Wheeler 1092 516 1703 1127 73 3.6k
Ralf A. Hilger 407 607 1207 1312 83 3.1k
J Cassidy 820 584 1627 1194 78 4.4k
H. M. Pinedo 575 357 1729 1339 98 3.2k
S. E. Salmon 818 417 1835 1609 77 3.8k

All Works

Loading papers...

Rankless by CCL
2026